IMS Health
Search results
Transforming Oncology Trials: Insights from Thought Leaders on FDA's Project Optimus. Learn more. Find out how IQVIA can reach your clinical development milestones faster with precision, expertise, and speed powered by data analytics.
- Global Laboratories
Q² Solutions combines the scale, clinical trial expertise,...
- Protocol Design
IQVIA offers a systematic approach integrating advanced...
- Phase IIb/III Trials
As science moves faster, research keeps pace. From emerging...
- Patient Recruitment
IQVIA is dedicated to helping ensure clinical trials are...
- Connected Devices
A proven biometric data analytics solution that combines...
- Phase I Trials
The IQVIA global network. All IQVIA network sites receive a...
- Clinical Trial Supplies
As clinical trials continue to increase in size and...
- Data Management
With an innovative and strategy-driven clinical data...
- Global Laboratories
With an innovative and strategy-driven clinical data management solution from IQVIA, accelerate the acquisition and validation of increasingly complex data throughout your trial from a broad range of sources.
1 day ago · IQVIA’s research and development solutions enables you to reimagine clinical development by leveraging advances in technology, analytics and human ingenuity.
Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
4 days ago · A new SaaS-based clinical data analytics platform from IQVIA Technologies harnesses structured and unstructured data into a single, standardized ecosystem for interrogation.
Jun 12, 2024 · IQVIA Prime Sites – clinical trial institutes or networks that are committed to long term relationships with IQVIA to improve and innovate clinical trial delivery – are currently piloting...
IQVIA Biotech delivers full-service clinical trial solutions — from early asset strategy and clinical development planning all the way to approval. Leverage our scientific experts, data and global resources so you can focus on what matters most: getting breakthrough treatments to patients.
